DSpace logo

Please use this identifier to cite or link to this item: http://142.54.178.187:9060/xmlui/handle/123456789/16101
Full metadata record
DC FieldValueLanguage
dc.contributor.authorFatima Lamchouri-
dc.contributor.authorMustapha Zemzami-
dc.contributor.authorJossang, Akino-
dc.contributor.authorSettaf, Abdellatif-
dc.contributor.authorZafar H Israili-
dc.contributor.authorLyoussi, Badiaa-
dc.date.accessioned2023-01-19T09:06:42Z-
dc.date.available2023-01-19T09:06:42Z-
dc.date.issued2013-07-07-
dc.identifier.citationLamchouri, F., Zemzami, M., Jossang, A., Abdellatif, A., Israili, Z. H., & Lyoussi, B. (2013). Cytotoxicity of alkaloids isolated from Peganum harmala seeds. Pak. J. Pharm. Sci, 26(4), 699-706.en_US
dc.identifier.issn1011-601X-
dc.identifier.urihttp://142.54.178.187:9060/xmlui/handle/123456789/16101-
dc.description.abstractEthnopharmacological relevance: Peganum harmala is used in traditional medicine to treat a number of diseases including cancer. Our preliminary studies show that the alkaloidal extract of PH seed is cytotoxic to several tumor cell lines in vitro and has antitumor effect in a tumor model in vivo. The present investigation was aimed at extending our previous studies in identifying the components in P. harmala seedextract responsible for the cytotoxic effects, and study the cytotoxic and antiproliferative activity of isolated alkaloids and total alkaloidal fraction (TAF) in several tumor cell lines. Four alkaloids: harmalicidine, harmine, peganine (vasicine) and vasicinone were isolated from the P. harmala seedextract and their activity and that of TAF were tested a) for their cytotoxic activity against four tumor cell lines [three developed by us by chemical-induction in Wistar rats: 1) Med-mek carcinoma ; 2) UCP-med carcinoma ; 3) UCP-med sarcoma] ; and 4) SP2/O-Ag14, and b) for antiproliferative effect on cells of Jurkat, E6-1 clone (inhibition of incorporation of {3 H-thymidine} in cellular DNA). The alkaloids and TAF inhibited the growth of tumor cell lines to varying degrees; Sp2/O-Ag14 was the most sensitive, with IC50 values (concentration of the active substance that inhibited the growth of the tumor cells by 50%) ranging between 2.43 µg/mL and 19.20 µg/mL, while UCP-med carcinoma was the least sensitive (range of IC50 = 13.83 µg/mL to 59.97 µg/mL). Of the substances evaluated, harmine was the most active compound (IC50 for the 4 tumor cell lines varying between 2.43 µg/ml and 18.39 µg/mL), followed by TAF (range of IC50 = 7.32 µg/mL to 13.83 µg/mL); peganine was the least active (IC50 = 50 µg/mL to > 100 µg/ml). In terms of antiproliferative effect, vasicinone and TAF were more potent than other substances: the concentration of vasicinone, and TAF needed to inhibit the incorporation of {3 H-TDR} in the DNA cells of Jurkat, E6-1 clone by 50% (IC50) were 8.60 ± 0.023 µg/mL and 8.94 ± 0.017 µg/mL, respectively, while peganine was the least active (IC50 >100 µg/mL). The IC50 values for harmalacidine (27.10 ± 0.011 µg/mL) and harmine (46.57 ± 0.011 µg/mL) were intermediate. The harmala alkaloids inhibited the growth of four tumor cell lines, and proliferation of Jurkat cells with varying potencies. Harmine was the most potent in inhibiting cell growth, and vasicinone was most active as antiproliferating substance. The TAF had significant cytotoxic as well as antiproliferating activity.en_US
dc.language.isoenen_US
dc.publisherKarachi: Faculty of Pharmacy & Pharmaceutical Sciences University of Karachien_US
dc.subjectPeganum harmalaen_US
dc.subjectharmineen_US
dc.subjectharmalacidineen_US
dc.subjectpeganine (vasicine)en_US
dc.subjectvasicinoneen_US
dc.subjectalkaloidsen_US
dc.subjectmurine tumor cellsen_US
dc.subjectcytotoxicityen_US
dc.subjectantiproliferating activityen_US
dc.subjectanticancer activityen_US
dc.subjectphytotherapyen_US
dc.titleCytotoxicity of alkaloids isolated from Peganum harmala seedsen_US
dc.typeArticleen_US
Appears in Collections:Issue 04

Files in This Item:
File Description SizeFormat 
Paper-7.htm142 BHTMLView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.